Multidrug-resistant Pseudomonas aeruginosa tracheotomy fistula infection
Conditions
Interventions
Intervention group:Oral/nasal feeding Swelling Jiefeng Tablet 0.5g/ tablet, oral, 3 tablets a time, 3 times a day, 14-day course
Conventional control group:Cluster management after routine tracheotomy
Sponsors
The First Affiliated Hospital of Guangxi Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: (1) 18-70 years old; (2) Patients needing tracheotomy after admission to ICU; (3) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) have been in the incubation period of respiratory tract infection or respiratory tract infection before ICU admission; (2) Patients with abnormal immune status other than tumor, including immunodeficiency diseases, taking immunodeficiency drugs; (3) pregnant women; (4) Patients who refuse to sign informed consent or quit midway.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Microbial culture; | — |
Secondary
| Measure | Time frame |
|---|---|
| White blood cell count;Interleukin 6;Procalcitonin;Hypersensitive C-reactive protein;CD4 /CD8lymphocyte; | — |
Countries
China
Contacts
Public ContactYiping Pan
The First Affiliated Hospital of Guangxi Medical University
Outcome results
None listed